Can You Start Semaglutide at 5mg or a Higher Dose?

You've seen '5mg' somewhere and now you're wondering if Wegovy works the same way

A common source of confusion: 5mg is a dose that exists for tirzepatide (Mounjaro), not for semaglutide (Wegovy). Tirzepatide follows a different milligram scale entirely, it starts at 2.5mg and steps through 5mg, 7.5mg and beyond. Semaglutide doses for weight management are measured on a much smaller scale: 0.25mg, 0.5mg, 1.0mg, 1.7mg, and 2.4mg, with 7.2mg now also available as a higher maintenance option following MHRA approval of a dedicated single-dose 7.2mg Wegovy pen in April 2026. If you've arrived here after researching tirzepatide, our page on how semaglutide compares to other weight-loss medicines covers the key differences side by side. The two medicines work differently at the receptor level and use entirely separate dosing frameworks, they can't be read across each other.

So the short answer is: 5mg of semaglutide doesn't exist in Wegovy's dose ladder. If someone is offering it, that's a significant red flag worth taking seriously.

What starting semaglutide actually looks like, and why the slow climb matters

The standard Wegovy titration opens at 0.25mg weekly. That dose isn't intended to produce noticeable weight loss; its job is to let your system settle into the medicine. GI side effects (nausea above all, but also reflux, constipation, loose stools) are most likely to appear when the dose is new or recently increased. Starting low and moving up in roughly four-week steps gives your gut time to adjust at each level before the next increase. By the time you reach the 2.4mg maintenance dose, most people's bodies have had months to adapt. You can read more about the full process on our guide to starting semaglutide.

Skipping the early stages doesn't accelerate weight loss in any meaningful clinical sense, it just front-loads the side effects without the tolerance your body builds through the gradual approach. The titration is part of the treatment, not a formality before the real thing begins. The NHS medicines page on semaglutide describes the standard schedule and what to expect at each stage, and is worth reading before or alongside any consultation.

A practical note: once you're established on Wegovy, your pen lives in the fridge door like any other temperature-sensitive medicine, the leaflet gives the exact room-temperature window if you need it for travel or clinic visits, and your prescriber can advise on brief deviations.

What a prescriber actually decides when treatment starts

When you consult through a regulated service, the prescriber isn't simply rubber-stamping a dose you've requested. They're reviewing your weight, BMI, any relevant health conditions, current medicines (particularly oral contraceptives, given the absorption interaction documented for tirzepatide, and discussed on our Wegovy overview page), and whether semaglutide is appropriate for you at all. Wegovy is licensed in the UK for adults with a BMI of 30 or above, or 27 to 29.9 alongside at least one weight-related condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea, but BMI alone isn't the whole picture. That clinical assessment is precisely why these medicines require a prescription.

The prescriber confirms the starting dose. For semaglutide, that starting dose is 0.25mg, not because higher isn't available, but because the licensed schedule begins there for everyone. Subsequent increases follow clinical review, not a fixed calendar. If you're thinking about whether Wegovy is the right route for you, our page on starting Wegovy walks through the full eligibility picture and what to expect at each step of the process.

When questions like this point to something worth addressing

People sometimes ask about starting at a higher dose because they've seen results claims online, or because they're impatient with what looks like a slow start. That's understandable. Clinical trials for Wegovy ran to 68 weeks; the meaningful weight-loss phase happens during and after reaching the maintenance dose, not during the tolerability build-up. Trying to compress that timeline by requesting an off-schedule dose isn't just ineffective, obtaining semaglutide in forms not prescribed through a licensed clinical pathway carries real risks. The MHRA has documented serious harm from counterfeit weight-loss medicines sold online, including products falsely labelled as semaglutide. If you're looking at cost as a factor, our page on accessing Wegovy through a regulated pharmacy explains what legitimate private treatment includes and what to look for when assessing a provider.

It's also worth knowing that treatment isn't necessarily permanent. Our page on pausing or stopping Wegovy covers what the evidence says about weight maintenance, which is a separate but important question from how to begin. Speak to our prescribers if you'd like to discuss whether semaglutide is right for you and what treatment through nume would involve, the consultation is free, and a real clinician reviews your answers the same day.